Výsledky vyhledávání - "Janusz Rudzinski"

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

Autor: Dariusz Kleczkowski, Satish Keshav, Milan Lukas, Fredrik Erlandsson, Silvio Danese, Yoram Bouhnik, Mark Berner Hansen, Mikael Knutsson, Peter Uebel, Wolfgang Brandt, Laurent Peyrin-Biroulet, Janusz Rudzinski, Jean Louis Dupas

Publikováno v: Gut
Gut, BMJ Publishing Group, 2015, 64 (2), pp.243-249. ⟨10.1136/gutjnl-2014-308004⟩

International audience; OBJECTIVE:Interleukin-13 (IL-13) has been implicated as a key driver of UC. This trial evaluates the efficacy and safety of tralokinumab, an IL-13-neutralising antibody, as add-on therapy in adults with moderate-to-severe UC d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70706808dac38525add1c984ed2a2804
https://pubmed.ncbi.nlm.nih.gov/28246312

Zobrazit plný text záznamu

One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease

Autor: Ann Larko, Zbigniew Bartuzi, Göran Hasselgren, Michael Wrangstadh, Dariusz Kleczkowski, Zsolt Tulassay, Petr Dite, Janusz Rudzinski, Andrzej Kryszewski

Publikováno v: European Journal of Gastroenterology & Hepatology. 13:1457-1465

Proton pump inhibitor (PPI) monotherapy is commonly continued for 3 weeks after Helicobacter pylori eradication with PPI-based triple therapy regimens to ensure duodenal ulcer (DU) healing. This randomized, double-blind, multicentre study evaluated w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dccfd711d7429f98dea1f88dbe26aacd
https://doi.org/10.1097/00042737-200112000-00009

Zobrazit plný text záznamu

OP011 Tralokinumab (CAT-354), an interleukin 13 antibody, in moderate to severe ulcerative colitis: A phase 2 randomized placebo-controlled study

Autor: Wolfgang Brandt, Dariusz Kleczkowski, Silvio Danese, Milan Lukas, M. Berner Hansen, Fredrik Erlandsson, L Peyrin-Biroulet, Mikael Knutsson, Yoram Bouhnik, Satish Keshav, Jean-Louis Dupas, Peter Uebel, Janusz Rudzinski

Publikováno v: Journal of Crohn's and Colitis. 8:S7-S8

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6f8c0866cd32ceee5733ea9ab67d8395
https://doi.org/10.1016/s1873-9946(14)60012-x

Zobrazit plný text záznamu

863 Tralokinumab (CAT-354), an Interleukin 13 Antibody, in Moderate to Severe Ulcerative Colitis: A Phase 2A Randomized Placebo-Controlled Study

Autor: Satish Keshav, Silvio Danese, Dariusz Kleczkowski, Mikael Knutsson, Milan Lukas, Janusz Rudzinski, Wolfgang Brandt, Laurent Peyrin-Biroulet, Jean-Louis Dupas, Yoram Bouhnik, Peter Uebel, Fredrik Erlandsson, Mark Berner Hansen

Publikováno v: Gastroenterology. 146:S-149

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68ac2cea2154bb665c4862f3717552d1
https://doi.org/10.1016/s0016-5085(14)60530-8

Zobrazit plný text záznamu

7-day treatment with esomeprazole-based triple therapy eradicates H. pylori (Hp) and heals patients with duodenal ulcer (DU) disease

Autor: Zbigniew Bartuz, Dariusz Kleczkowski, Ann Larko, Andrzej Kryszewski, Michael Wrangstadh, Göran Hasselgren, Zsolt Tulassay, Petr Dite, Janusz Rudzinski

Publikováno v: Gastroenterology. 118:A502

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa019413c397ca4a8c9a4df48188ef87
https://doi.org/10.1016/s0016-5085(00)84132-3

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání